Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists discover role for c-myc gene in tumor angiogenesis

01.10.2002


The c-myc gene is commonly activated in a variety of human tumors. As a new report in the October 1 issue of Genes & Development shows, scientists are gaining a better understanding as to why.



Dr. John Cleveland and colleagues at St. Jude Children’s Research Hospital have discovered that c-Myc is essential for tumor development, as it regulates factors necessary for the growth of blood vessels into tumors – lending a new potential target to anti-angiogenic cancer therapies.

The myc family of oncogenes (c-myc, N-myc, and L-myc) function in the control of cell proliferation, differentiation, and tumorigenesis. Although it has long been recognized that c-Myc’s positive effect on cell proliferation can contribute to cancer development, scientists have also suspected that c-Myc has additional roles in the progression of malignancy. Dr. Cleveland and colleagues have discovered such a role: c-Myc is essential for tumor angiogenesis.


Growing tumors need oxygen and nutrients to survive. Once a tumor’s demand for oxygen and nutrients exceeds what the existing vasculature can provide, a new vascular network is established (vasculogenesis) and capillaries are formed (angiogenesis) to meet the tumor’s increasing needs. Since the late nineties, when the first anti-angiogenic drugs entered clinical trials, much interest has centered upon the therapeutic approach to thwart a tumor’s growth by cutting off its blood supply. By showing that c-Myc is essential for promoting vasculo- and angiogenesis, Dr. Cleveland and colleagues have uncovered another possible route in this anti-angiogenic strategy.

"The goal of this study was to determine the role of c-Myc in development. These studies established that c-Myc is essential for the formation of the vasculature that distributes blood throughout the organism, and that it did so by functioning as a master regulator of factors that are necessary for the growth of blood vessels and capillaries. The surprising result was that these studies also revealed why MYC family genes are activated in 70% of all human cancers," explains Dr. Cleveland.

To evaluate the physiological role of c-Myc, Dr. Cleveland and colleagues re-derived a strain of transgenic mice that are deficient in the gene. The c-myc-deficient mice die as embryos due to cardiac and neural defects, but also display marked defects in vasculogenesis, angiogenesis, and the formation of red blood cells. The researchers found that the vascular defects in the c-Myc-deficient mice arise from the mis-expression of intercellular signals that coordinate vasculo- and angiogenesis during development.

Drs. Cleveland and Baudino and colleagues went on to show that c-Myc plays a similar role in orchestrating vasculogenesis during tumor formation. The researchers demonstrated that c-Myc-deficient embryonic stem cells have a diminished ability to form tumors in immunocompromised mice, and that the small tumors that sometimes form have dramatically less vasculature. Further delineation of role of c-Myc in promoting human tumorigenesis is needed, but as it stands, this study presents strong evidence to suggest that the disruption of c-Myc may prove successful as an anti-angiogenic tool in cancer therapy.

Heather Cosel | EurekAlert!
Further information:
http://www.cshl.org/

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>